Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

NCT02621164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: NBP607-QIV
BIOLOGICAL: Agrippal S1

Sponsor

SK Chemicals Co., Ltd.